Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ivana Golubović"'
Publikováno v:
Medicina, Vol 59, Iss 9, p 1564 (2023)
Background: Previous research has shown different effects of hematological malignancies on the outcome of patients with COVID-19 infection depending on the type of disease and the treatment received. This research was aimed at examining the clinical
Externí odkaz:
https://doaj.org/article/3fbf2869d78f423ab4a139ad2c8fe587
Publikováno v:
Saudi Pharmaceutical Journal, Vol 27, Iss 8, Pp 1216-1221 (2019)
Imatinib mesylate (IM) is the first developed protein kinase inhibitor and recently it has topped consumption rates among targeted and total anticancer drugs. Although there are indications that IM possesses cyto/genotoxic activities against normal n
Externí odkaz:
https://doaj.org/article/a49e3cdf24ab453c8a73a79b534d88dd
Autor:
Saša Stojanović, Predrag Stojiljković, Golubović Ivan, Ivica Lalić, Danilo Stojiljković, Marko Kadija, Ivana Golubović, Zoran Radovanović, Mila Janjić, Zoran Golubović, Miroslav Trajanović
Publikováno v:
Acta Medica Medianae, Vol 53, Iss 4, Pp 30-36 (2014)
Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disorder of unknown etiology characterized by synovial hyperplasia and resulting joint destruction. Despite reduced needs for total joint arthroplasty in the treatment of end-stage damag
Externí odkaz:
https://doaj.org/article/abe8acc6df6d400894888375bd554e50
Autor:
Milica Bjelaković, Daniela Benedeto Stojanov, Ivana Golubović, Marko Bjelaković, Marko Gmijović
Publikováno v:
Acta Medica Medianae. 60:72-81
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3403a4a01f4469bb8b4edb6b747300b
https://doi.org/10.5633/amm.2021.0410
https://doi.org/10.5633/amm.2021.0410
Autor:
Zoran Golubović, Predrag Stoiljković, Ivan Golubović, Milan Pejčić, Milan Lazarević, Mihailo Ille, Ivana Golubović, Ivan Milošević, Nebojša Mitić, Dejan Tabakavić
Publikováno v:
Timocki medicinski glasnik. 46:132-136
Segmental tibial fractures belong to the group of the most severe fractures of the locomotor system. They are most common in polytraumatized patients. Treatment of segmental tibial fractures can be conservative or operative. Treatment of segmental ti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20690be8358d580a9b4c8018baa894ff
https://doi.org/10.5937/tmg2103132g
https://doi.org/10.5937/tmg2103132g
Publikováno v:
Acta stomatologica Naissi. 36:2007-2010
Introduction: Despite substantial advances in the treatment of Hemophilia A with the use of concentrated factor VIII preparations during recent decades, bleeding episodes still occur from time to time. The development of inhibitors significantly redu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c65130a2692e77bf4740f5ab7ce37e49
https://doi.org/10.5937/asn2081007t
https://doi.org/10.5937/asn2081007t
Autor:
Ivan Golubović, Predrag Stojiljković, Mihailo Ille, Milan Radojković, Nemanja Jovanović, Milan Lazarević, Ivana Golubović, Ivan Milošević, Zoran Baščarević, Dejan Tabaković, Nebojša Mitić
Publikováno v:
Timočki medicinski glasnik (2022) 47(2-3):119-125
Introduction. Leg conquassation caused by petrol tiller is one of the most severe injuries in bone and joint traumatology. Firm strokes by sharp tiller blades produce strong force that easily damages both soft tissues and bones. Since tillers are use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73df99c5f9b51ef3a43da1bd4436e779
http://scindeks.ceon.rs/article.aspx?artid=0350-28992202119G
http://scindeks.ceon.rs/article.aspx?artid=0350-28992202119G
Publikováno v:
Toxicon : official journal of the International Society on Toxinology. 187
Domoic acid (DA) is an excitatory marine neurotoxin produced by diatoms Pseudo-nitzschia spp. as a defence compound that accumulates in the food web and is associated with amnesic shellfish poisoning in humans. Although its toxicity has been well est
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25c424b51b0663817c032dc4d4ca118f
https://pubmed.ncbi.nlm.nih.gov/32891664
https://pubmed.ncbi.nlm.nih.gov/32891664
Publikováno v:
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal, Vol 27, Iss 8, Pp 1216-1221 (2019)
Saudi Pharmaceutical Journal, Vol 27, Iss 8, Pp 1216-1221 (2019)
Imatinib mesylate (IM) is the first developed protein kinase inhibitor and recently it has topped consumption rates among targeted and total anticancer drugs. Although there are indications that IM possesses cyto/genotoxic activities against normal n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ba92e6f8d1c316bf704917f873504ca
https://www.bib.irb.hr/1273280
https://www.bib.irb.hr/1273280
